Here are relevant reports on : diagnostic-disinfectant-market
-
Clinical Microbiology Market by Product (Instrument (Incubators), Analyzer (Microscope), Reagent, Kits, Media], Disease Area (Respiratory, Gastrointestinal, STD, UTI), End User (Hospitals, Diagnostic Center, Research Institutes) - Global Forecast to 2030
The global clinical microbiology market, valued at US$5.08 billion in 2024, stood at US$5.33 billion in 2025 and is projected to advance at a resilient CAGR of 6.6% from 2025 to 2030, culminating in a forecasted valuation of US$7.34 billion by the end of the period. A key factor contributing to market growth is the rising technological advancements that have enabled the development of advanced microbial identification methods and improved antibiotic susceptibility testing.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
4D Imaging Radar Market by Range (Short-Range, Medium-Range, Long-Range), Application (ADAS, Security & Surveillance, Patient Diagnostic & Monitoring, End User (Automotive, Aerospace & Defense, Healthcare, Industrial) - Global Forecast to 2030
The 4D imaging radar market is expected to grow from USD 392.8 million in 2025 to USD 1,206.9 million by 2030, at a compound annual growth rate (CAGR) of 25.2% during the forecast period. The Key Players Texas Instruments Incorporated (US), NXP Semiconductors (Netherlands), Infineon Technologies AG (Germany), Robert Bosch GmbH (Germany), Mobileye (Israel), Vayyar (Israel), Uhnder (US), Arbe (Israel), Thales (France), Continental AG (Germany), and Magna International Inc. (Canada).
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Oligonucleotide CDMO Market by Service (Contract Manufacturing (Clinical, Commercial), Development), Type (ASO, SiRNA, (CPG Oligos, gRNA)), Application (Therapeutic, Research, Diagnostic), End User (Pharma, Biotech) - Global Forecast to 2029
The global oligonucleotide CDMO market, valued at US$2.33 billion in 2023, stood at US$2.51 billion in 2024 and is projected to advance at a resilient CAGR of 21.8% from 2024 to 2029, culminating in a forecasted valuation of US$6.73 billion by the end of the period. The increasing focus on precision/personalized medicine is also likely to contribute to market growth. Growing opportunities offered by emerging economies are accelerating innovation in the oligonucleotide CDMO field.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Veterinary Infectious Disease Diagnostics Market by Product (Consumables, Instruments), Technology (Molecular Diagnostic, PCR, ELISA, Immunodiagnostics, Rapid Tests), Animal Type (Companion Animal, Livestock), End User & Region - Global Forecast to 2030
The global veterinary infectious disease diagnostics market, valued at US$2.66 billion in 2024, stood at US$2.87 billion in 2025 and is projected to advance at a resilient CAGR of 8.0% from 2025 to 2030, culminating in a forecasted valuation of US$4.22 billion by the end of the period.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Neurodiagnostics Market by Product (Diagnostic & Imaging Systems (MRI, Ultrasound), Clinical Testing (PCR, NGS), Reagents & Consumables), Disease Pathology (Epilepsy, Stroke), End User and Region - Global Forecasts to 2024
The neurodiagnostics market is projected to reach USD 8.4 billion by 2024, at a CAGR of 7.3%. Some of the prominent players in this market includes GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), Hitachi, Ltd. (Japan), Canon, Inc. (Japan), Lifelines Neuro Company, LLC (US), Natus Medical Incorporated (US), Hoffman-La Roche AG (Switzerland), FUJIFILM Holdings Corporation (Japan), Mitsar Co., Ltd. (Russia), Advanced Brain Monitoring (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories (US), QIAGEN N.V. (Netherlands), Nihon Kohden Corporation (Japan), ANT Neuro (Netherlands), Fonar Corporation (US), Fujirebio (Japan), DRG Instruments GmbH (Germany), Tecan Trading AG (Switzerland), Motion Lab Systems, Inc. (US), Rigaku Corporation (Japan), Neusoft Medical Systems Co., Ltd. (US), ELMIKO MEDICAL Sp. Z o.o. (Poland) and Ridge Diagnostics (US).
- Published: December 2019
- Price: $ 4950
- TOC Available:
-
Medical Immersive Simulation Market by Tech (VR, AR, Haptics VR, AI), Offering (Hardware, Software, Services), Application (Medical, Procedural, Surgery, Emergency, Anatomy, Diagnostic), End User (Academic Institutes, Hospitals) - Global Forecast to 2030
The global medical immersive simulation market is projected to reach USD 1.37 billion by 2030, growing at a CAGR of 12.3% during the forecast period (2025–2030). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
AI Agents in Healthcare Market by Function (Scheduling, Billing, Diagnostic, Treatment, RPM, Telehealth), Offering (Multi-Agent), Architecture (Contextual, Conversational), End User (Hospital, ACS, Imaging Center), Trends, Growth - Global Forecast to 2030
The global AI Agents in Healthcare market, valued at US$0.76 billion in 2024, stood at US$1.11 billion in 2025 and is projected to advance at a resilient CAGR of 44.1% from 2025 to 2030, culminating in a forecasted valuation of US$6.92 billion by the end of the period. Advances in generative AI, natural language processing, and seamless integration with electronic health records (EHRs) are enabling AI agents to handle a range of tasks, from patient engagement and appointment scheduling to clinical decision support and documentation assistance.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
E.coli Test Market by test (Environmental (Membrane Filtration, Multiple Tube Fermentation), Clinical (Polymerase Chain Reaction, Enzyme Immunoassays)) End User (Hospital, Diagnostic Laboratories, Physician Offices) - Global Forecasts to 2023
The global E.coli test market is expected to reach USD 2.05 billion by 2023 from USD 1.38 billion in 2018, growing at a CAGR of 8.2%. Increasing awareness regarding hygienic, government regulations regarding water and food management, government funding for performing diagnostic tests, non-government organizations (NGO’s) campaigns on water management, increasing prevalence of diarrhoea cases are the major driving factors for this market.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Electron Microscopy Market by Product (Scanning, transmission, cryo-electron microscope), Application (Pathology & histology, pathogen, drug target analysis), Enduser (Pharma-biopharma, diagnostic lab, academia, nanotechnology labs) - Global Forecast to 2031
The global electron microscopy market is projected to reach USD 2.22 billion by 2031, growing at a CAGR of 5.5% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Medical Image Management Market by Product (PACS (Departmental, Radiology, Mammography, Cardiology, Enterprise), VNA (On-premise, Hybrid, Cloud), AICA, Universal Viewer), End User (Hospitals, Diagnostic Imaging Centers, ASC, CRO) - Global Forecast to 2023
The medical image management market is projected to reach USD 4.40 billion in 2023, growing at a CAGR of 7.7% . Prominent players in this market include McKesson Corporation (US), GE Healthcare (US), Fujifilm Holdings Corporation (Japan), Merge Healthcare Inc. (US), Agfa-Gevaert Group (Belgium), Philips Healthcare (Netherlands), Siemens Healthineers (Germany), Carestream Health, Inc. (US), BridgeHead Software (UK), Novarad Corporation (US), Mach7 Technologies Ltd. (US), and INFINITT Healthcare Co., Ltd.(South Korea).
- Published: August 2018
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
